The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RPT-ANALYSIS-Buy yen in crisis? Not this year

Wed, 25th Jul 2018 07:00

* Yen weakest G10 currency this month despite globalturbulence

* Investors doubt BOJ can reduce stimulus aggressively

* Japanese purchases of foreign equities highest in nearly 3years

* Bond investors growing reluctant to hedge foreign holdings

* Japanese firms spend record sum on foreign acquisitions inH1

By Tom Finn and Hideyuki Sano

LONDON/TOKYO, July 24 (Reuters) - The trade is familiar toinvestors worldwide: in times of turmoil, rush for cover bybuying the Japanese yen.

This year a global trade row has erupted, Donald Trump haslamented the dollar's strength - ignoring a custom that U.S.presidents avoid openly interfering in financial markets - andthe Chinese yuan has tumbled.

And yet the yen has stayed resolutely weak, becoming theweakest of the G10 developed market currencies this month.

The yen's safe-haven status is not in doubt, underpinned byJapan's nearly two trillion yen ($18 billion) monthly tradesurplus. But without a massive world market shock to discourageJapanese investors from buying foreign assets, the yen is likelyto stay weak - above all because the Bank of Japan lags behindits central bank peers in ending monetary stimulus.

Investors doubt the BOJ can aggressively reduce the stimulusmeasures as inflation remains well below target and corporateprofits are recovering slowly.

The BOJ is debating policy changes to make its stimulus"more sustainable", sources told Reuters, but this pushed theyen up only briefly on Monday.

"The Bank of Japan is still pursuing easing which is stillprompting domestic investors to borrow yen and buy overseasassets," said Anton Eser, CIO at Legal and General InvestmentManagement which manages 983 billion pounds ($1.29 trillion) inassets.

While U.S. interest rates have risen seven times since 2016and the European Central Bank plans to wind down its bondpurchases by end-2018, the BOJ is still buying local securities,albeit at a slower pace.

Japanese investors are therefore likely to keep pouringmoney into foreign assets, despite global market wobbles.

Their net purchases of foreign equities reached 1.5 trillionyen in June, the highest in nearly three years. Even as thetrade row deepened, they bought 371 billion yen of overseasstocks during the first week of July.

HEDGE TRIMMING

However, Japanese funds are growing reluctant to hedgeexposure to billions of dollars' of U.S. assets.

"I suspect some investors are reducing currency hedge ontheir foreign bond investments," a senior trader at a majorJapanese bank in Tokyo told Reuters, requesting anonymity.

Japanese fund managers buying 10-year U.S. Treasuries on afully hedged basis now earn a slim 33 basis points in yield,compared with 50-80 bps last year. As the Federal Reserve keepsraising interest rates, even that yield advantage could vanish.

And a lack of demand for yen from investors in the currencyforwards market would feed into falling spot market demand.

"Currency hedging costs have risen rapidly. Japaneseinvestors have stopped hedging. That stops them buying the yen.The flow is for selling yen," said Adam Cole, chief currencystrategist at RBC in London.

Another source of yen selling is Japanese companies makingacquisitions overseas due to lacklustre economic growth and ashrinking population at home. Thomson Reuters data showsJapanese investors spent a record 13.0 trillion yen on foreignacquisitions in the first half of the year.

These included Takeda Pharmaceutical's $62 billionacquisition of London-listed drugmaker Shire Plc.

Initially the deal helped to push the British pound up morethan four percent against the yen in early-April, but in Maytraders started to buy dollars on news that Takeda's payment toShire shareholders would be in dollars.

TRADE WINDS

Trade conflict would seem yen-positive by raising globalmarket volatility. In fact, this is helping to push it down.

Japan is vulnerable to a trade war. Autos, for instance,comprise almost 30 percent of its exports to the United Statesand new U.S. tariffs could hurt Tokyo's vaunted trade surplus.

Also, as fund managers worldwide cut foreign investmentholdings, much of this cash is going to U.S. markets instead ofthe "safe havens". The dollar is likely to benefit from a tradewar due to the United States' lower reliance on exports.

"Rather than move into the Swiss franc or the Japanese yen,the widening interest rate differential in favour of the U.S.dollar is currently providing investors with a strongalternative," Rabobank currency strategist Jane Foley said.

Global investors now hold their biggest overweight positionin U.S. equities in 17 months, Bank of America Merrill Lynch'spoll showed last week. Other equity holdings have fallen andallocations to Japan slid for the third time in four months.

Correlation has been high this year between Japanese stocksand the yen, with both losing ground, BAML's FX strategist KamalSharma noted. That's unusual because yen weakness usually booststhe Nikkei average.

"If U.S. share markets crumbled, then we would be in adifferent situation," the Tokyo-based trader said. "But as longas Wall Street is in the risk-on mode, the dollar will besupported against the yen."($1 = 111.2400 yen)($1 = 0.7629 pounds)

(Additional reporting by Shinji Kitamura and Tommy Wilkes;Graphic by Ritvik Carvalho; Writing by Saikat Chatterjee;Editing by Sujata Rao and David Stamp)

More News
4 Jan 2019 12:09

LONDON MARKET MIDDAY: Miners Keep FTSE Higher Ahead Of US Payrolls

LONDON (Alliance News) - Stocks in London remained higher midday Friday buoyed by miners, confirmed US-China trade talks and positive Chinese economic data.The FTSE 100 index was up 92.54 points,

Read more
6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

Read more
5 Dec 2018 17:12

LONDON MARKET CLOSE: Stocks End Lower Amid Global Growth Fears

LONDON (Alliance News) - Stocks in London ended lower on Wednesday as concerns over global growth and trade wars continued to plague investors. The FTSE 100 index closed down 100.92 points, or at

Read more
5 Dec 2018 13:58

UPDATE: Takeda, Shire Secure Deal Approval From Shareholders

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 12:12

LONDON MARKET MIDDAY: Risk-Off Mood As Weak UK Services Adds To Worry

LONDON (Alliance News) - London stocks slid on Wednesday as risk-off sentiment replaced the more upbeat mood at start of the week, with markets in the US and Asia slumping overnight amid global of

Read more
5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more
5 Dec 2018 08:44

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US yields

Read more
5 Dec 2018 08:40

LONDON MARKET OPEN: Stocks Sink Amid Trade War, US Economy Jitters

LONDON (Alliance News) - With Monday's gains a distant memory, the FTSE 100 shed nearly 100 points at the London open Wednesday amid renewed global trade fears and worries over the strength of

Read more
5 Dec 2018 08:00

Takeda shareholders approve £46bn Shire takeover

(Sharecast News) - Takeda Pharmaceutical shareholders have approved its £46bn takeover of London-listed pharmaceutical group Shire.

Read more
5 Dec 2018 06:58

LONDON MARKET EARLY CALL: FTSE 100 Seen Down 60 Points After NY Fall

LONDON (Alliance News) - Stocks in London are set to open sharply lower on Wednesday following a slump in New York overnight that was tracked by Asian markets, with the optimism seen at the start

Read more
5 Dec 2018 06:43

TOP NEWS: Takeda Shareholders Approve Acquisition Of Shire

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 04:06

UPDATE 1-Takeda shareholders give nod for $59 bln Shire acquisition

* Deal is the biggest overseas acquisition by Japanese firm * Some had opposed massive debt required for deal * CEO Weber has promised to slash costs (Adds details about Takashi Dec

Read more
5 Dec 2018 03:32

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 (Reuters) - Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a but

Read more
2 Dec 2018 11:57

Sunday newspaper round-up: US-China, Brexit, Royal Mail, Barclays, Shire

(Sharecast News) - China and the United States have agreed to halt additional tariffs as both nations engage in new trade negotiations with the goal of reaching an agreement within 90 days, the White House said on Saturday after talks between President Donald Trump and President Xi Jinping in Argentina. - Sunday Telegraph

Read more
30 Nov 2018 08:35

Shire Wins European Okay For Takhzyro Drug Ahead Of January Delisting

LONDON (Alliance News) - Shire PLC said Friday its Takhzyro injection has been approved in Europe to treat hereditary angioedema.Takhzyro is a preventative treatment for hereditary a that a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.